Molinalogo

Measure

2022

2023

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

56.12%

58.89%

64.90%

Annual Dental Visits (ADV) Total

56.14%

41.82%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

41.50%

36.41%

46.74%

Appropriate Testing for Pharyngitis (CWP)

66.04%

67.80%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI)

89.93%

89.92%

93.08%

Asthma Medication Ratio (AMR) Total

61.16%

58.23%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

42.67%

56.96%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

65.45%

63.99%

68.61%

Breast Cancer Screening (BCS)

47.50%

46.73%

55.25%

Cervical Cancer Screening (CCS)

52.47%

51.85%

59.85%

Childhood Immunization Status (CIS) Combination #10

36.01%

30.90%

35.04%

Chlamydia Screening in Women (CHL) Total

64.57%

64.63%

61.07%

Controlling High Blood Pressure (CBP)

50.36%

55.72%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

77.01%

76.33%

80.86%

Eye Exam for Patients With Diabetes (EED)

48.91%

52.80%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence

(FUA) 7-Day Follow-Up Total

17.86%

29.81%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

52.21%

52.64%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

39.15%

34.51%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

52.98%

51.03%

37.31%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

57.36%

57.17%

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

57.42%

51.58%

55.72%

Immunizations for Adolescents (IMA) Combination #2

34.31%

32.67%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Rate Total

24.01%

37.20%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

27.67%

29.12%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

31.04%

32.05%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

16.58%

14.08%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

78.29%

78.10%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

86.76%

88.52%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

98.12%

95.06%

≤ 92.72%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

83.21%

82.73%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

75.67%

73.72%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

20.96%

18.36%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

1.36%

1.45%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

82.78%

82.81%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

66.53%

63.09%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

68.30%

67.89%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

65.35%

60.75%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

77.30%

76.66%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

68.68%

67.83%

75.44%

Use of Opioids at High Dosage (HDO)

1.99%

2.21%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

1.57%

1.43%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

74.21%

74.94%

83.21%